Sacubitrivex (Sacuvance)
Product detail for Sacubitrivex, INN: sacubitrivex. Therapeutic area: Cardiovascular. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-022
INN
sacubitrivex
Therapeutic Area
Cardiovascular
Status
In Progress
Owner
Sarah Chen
Created
2022-02-25
Last Updated
2023-06-04
Markets
12
Presentations
| Form | Strength | Route |
|---|---|---|
| Oral solution | 200 mg | Topical |
| Ophthalmic solution | 200 mg | Intravitreal |
| Transdermal patch | 5 mg | Topical |
| Inhalation powder | 50 mg | Inhalation |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-005 | Immunovant alfa | immunovant alfa | 45534-14-3 | biologic | Active |
| SUB-008 | Alzabistat | alzabistat | 55813-84-2 | biologic | Active |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| EMA-2023-0022 | Saudi Arabia | MAA | Blocked | Marcus Webb | 2023-12-06 |
| HSA-2023-0052 | Saudi Arabia | Type IA Variation | Active | Aisha Okonkwo | 2022-05-26 |
| EMA-2023-0082 | Saudi Arabia | NDA | Blocked | Dmitri Volkov | 2023-12-13 |
Markets (12)